Odyssey Health (ODYY) Loans and Notes Receivables (2019 - 2020)
Odyssey Health's quarterly Loans and Notes Receivables came in at $100000.0 in Q2 2020, up 100.0% quarter-over-quarter from $50000.0 in Q3 2019.
Odyssey Health has reported Loans and Notes Receivables for 2 years, with the latest figure at $100000.0 in Q2 2020.
- For the quarter ending Q2 2020, Loans and Notes Receivables changed N/A year-over-year to $100000.0; the trailing twelve-month figure through Apr 2020 stood at $100000.0 (changed N/A YoY), and the FY2019 full-year result was $50000.0, changed N/A from the prior year.
- Loans and Notes Receivables for Q2 2020 stood at $100000.0, up from $50000.0 in the prior quarter.
- The five-year high for Loans and Notes Receivables was $100000.0 in Q2 2020, with the low at $50000.0 in Q3 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Loans & Notes Receiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Odyssey Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2020 | 100,000.00 |
| Jul 31, 2019 | 50,000.00 |